Can an antisense oligonucleotide (ASO) targeting an RNA that is neither coding nor encoded by a gene extend the lifespan of a mammal? https://t.co/24p4d7TskP
#DDRNA#ncRNA#telomere#aging#ASO
🚨 Can we kill a cell by targeting DNA that does nothing?
🧬 Our study shows Cas9 can selectively kill cells carrying a non-functional target sequence, sparing cells without it.
Weaponizing CRISPR/Cas9 for selective elimination of cells with an abe… https://t.co/s5Upaf1UgQ
🚨 Can broken DNA generate a new protein?
Our study independently confirms that DSBs trigger transcription from the break—and shows, for the first time, that the resulting RNA can be translated.
Could this generate neoantigens after radio/chemotherapy?
https://t.co/r7R5lNDvoZ
Disclosure: I co-founded TAG Therapeutics, exploring clinical development of this approach — this study was independent academic work.
📄 IPF paper: https://t.co/ryoVBvgsJI
Together: #tASOs (the molecules we use) look like a real shot at treating #Telomere Biology Disorders (#TBD) broadly — IPF, bone marrow failure, and more.
Online now!✨Oppezzo et al therapeutically block telomeric DNA damage signalling to restore hematopoietic function in telomerase-deficient and aged mice, while reducing senescence and inflammation
@FdAdF66@IFOMresearch https://t.co/7F6xZXDFa3
1/ What if some of the consequences of #aging are not caused by damage itself, but by the alarm signals our cells generate in response to that #damage?
Today, we publish a study in @NatureAging addressing this question.
https://t.co/KZJssN3br5